1 |
Takada M, Nakanome H, Kishida M, Hirose S, Hasegawa T, Hasegawa Y. Measurement of free insulin-like growth factor-I using immunoradiometric assay. J Immunoassay 1994;15:263-76
DOI
|
2 |
Juul A, Dalgaard P, Blum WF, Bang P, Hall K, Michaelsen KF, et al. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab 1995;80:2534-42
DOI
|
3 |
Hasegawa Y, Hasegawa T, Takada M, Tsuchiya Y. Plasma free insulin-like growth factor I concentrations in growth hormone deficiency in children and adolescents. Eur J Endocrinol 1996;134:184-9
DOI
|
4 |
Nimura A, Katsumata N, Tanaka T. Serum levels of free insulin-like growth factor (IGF)-I in normal children. Clin Pediatr Endocrinol 2004;13:71-8
DOI
ScienceOn
|
5 |
Juul A, Holm K, Kastrup KW, Pedersen SA, Michaelsen KF, Scheike T, et al. Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency. J Clin Endocrinol Metab 1997;82:2497-502
DOI
|
6 |
Rose SR, Municchi G, Barnes KM, Kamp GA, Uriarte M, Ross JL. Spontaneous growth hormone secretion increases during puberty in normal girls and boys. J Clin Endocrinol Metab 1991;73:428-35
DOI
|
7 |
Jorgensen JO, Blum WF, Moller N, Ranke MB, Christiansen JS. Circadian patterns of serum insulin-like growth factor (IGF) II and IGF binding protein 3 in growth hormonedeficient patients and age- and sex-matched normal subjects. Acta Endocrinol (Copenh) 1990;123:257-62
|
8 |
Manousos O, Souglakos J, Bosetti C, Tzonou A, Chatzidakis V, Trichopoulos D, et al. IGF-I and IGF-II in relation to colorectal cancer. Int J Cancer 1999;83:15-7
DOI
ScienceOn
|
9 |
Hasegawa Y, Hasegawa T, Fujii K, Konii H, Anzo M, Aso T, et al. High ratios of free to total insulin-like growth factor-I in early infancy. J Clin Endocrinol Metab 1997;82:156-8
DOI
|
10 |
Kawai N, Kanzaki S, Takano-Watou S, Tada C, Yamanaka Y, Miyata T, et al. Serum free insulin-like growth factor I (IGF-I), total IGF-I, and IGF-binding protein-3 concentra-tions in normal children and children with growth hormone deficiency. J Clin Endocrinol Metab 1999;84:82-9
DOI
|
11 |
Yamada M, Hasegawa T, Hasegawa Y. Increase in free insulin-like growth factor-I levels in precocious and normal puberty. Endocr J 1998;45:407-12
DOI
ScienceOn
|
12 |
Lee PDK, Powell D, Baker B, Liu F, Mathew G, Levitsky I, et al. Characterization of a direct, non-extraction immunoradiometric assay for free IGF-I. Program and abstracts, the 76th annual meeting of the Endocrine Society; 1994 June 15-18, Anaheim, Calif, USA: Endocrine Societ
|
13 |
Sneppen SB, Lange M, Pedersen LM, Kristensen LO, Main KM, Juul A, et al. Total and free insulin-like growth factor I, insulin-like growth factor binding protein 3 and acid-labile subunit reflect clinical activity in acromegaly. Growth Horm IGF Res 2001;11:384-91
DOI
ScienceOn
|
14 |
Song AK, Kim HJ, Suk HJ, Hwang JS, Hong CH. Serum IGF-I and IGFBP-3 in 919 healthy Korean children and adolescents: normal values and correlations with age, sex, height, body mass index and bone age. J Korean Soc Pediatr Endocrinol 2005;10:35-41
|
15 |
Musolino NR, Da Cunha Neto MB, Marino Junior R, Giannella-Neto D, Bronstein MD. Evaluation of free insulinlike growth factor-I measurement on the diagnosis and follow- up treatment of growth hormone-deficient adult patients. Clin Endocrinol (Oxf) 1999;50:441-9
DOI
ScienceOn
|
16 |
Frystyk J, Skjaerbaek C, Dinesen B, Orskov H. Free insulinlike growth factors (IGF-I and IGF-II) in human serum. FEBS Lett 1994;348:185-91
DOI
ScienceOn
|
17 |
Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 1998;279:563-6
DOI
ScienceOn
|
18 |
Juul A, Bang P, Hertel NT, Main K, Dalgaard P, Jorgensen K, et al. Serum insulin-like growth factor-I in 1030 healthy children, adolescents and adults; relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab 1994;78:744-52
DOI
|
19 |
Hasegawa Y, Hasegawa T, Aso T, Kotoh S, Tsuchiya Y, Nose O, et al. Usefulness and limitation of measurement of insulin-like growth factor binding protein-3 (IGFBP-3) for diagnosis of growth hormone deficiency. Endocrinol Jpn 1992;39:585-91
DOI
ScienceOn
|
20 |
Rosenfield RI, Furlanetto R, Bock D. Relationship of somatomedin- C concentrations to pubertal changes. J Pediatr 1983;103:723-8
DOI
|
21 |
Rosenfeld RG, Kemp SF, Hintz RL. Constancy of somatomedin response to growth hormone treatment of hypopituitary dwarfism, and lack of correlation with growth rate. J Clin Endocrinol Metab 1981;53:611-7
DOI
|
22 |
Hizuka N, Takano K, Asakawa K, Sukegawa I, Fukuda I, Demura H, et al. Measurement of free form of Insulin-like growth factor I in human plasma. Growth Regul 1991;1:51-5
|
23 |
Shimasaki S, Ling N. Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5, and -6). Prog Growth Factor Res 1991;3:243-66
DOI
ScienceOn
|
24 |
Cara JF, Rosenfield RL, Furlanetto RW. A longitudinal study of the relationship of plasma somatomedin-C concentration to the pubertal growth spurt. Am J Dis Child 1987;141:562-4
|
25 |
Juul A, Flyvbjerg A, Frystyk J, Muller J, Skakkebaek NE. Serum concentrations of free and total insulin-like growth factor-I, IGF binding proteins-1 and -3 and IGFBP-3 protease activity in boys with normal or precocious puberty. Clin Endocrinol (Oxf) 1996;44:515-23
DOI
ScienceOn
|